Chordia Therapeutics Inc. (JP:190A) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Chordia Therapeutics Inc., a clinical-stage biotech company in Japan, has released a corporate research report through Fisco Corporation. The company is advancing its lead asset, rogocekib, a cancer therapy currently in Phase 1/2 trials in the US, and is working on other promising preclinical cancer treatments. This development could be of interest to investors tracking innovative cancer therapies and biotech advancements.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.